Merck treads water in Q4 as Keytruda helps offset Remicade suffering

Tracy Staton Merck & Co. took a one-two punch in the fourth quarter. Revenue from two top-selling franchises–Januvia and Remicade–slid, dragging overall ...

Drug price increases saw ‘high water mark’ year in 2015: Analysts

Emily Wasserman Price hikes have landed pharma in hot water lately, with lawmakers, the public and presidential hopefuls lashing out at companies over skyrocketing costs. But things ...

FDA staffers throw cold water on Sanofi’s Lemtrada hopes

Tracy Staton If you're a drug developer, which 6 words do you never, ever want to see in an FDA review of a potential new product? The 6 words applied to Sanofi's multiple sclerosis ...

Analysts continue to pour cold water on hot Alexion buyout rumors

John Carroll If Roche does actually pull the trigger on a rumored bid for Alexion, you can expect analysts to react with some scathing assessments. FierceBiotech News

Europe Creates A Water Pollution Watch List For Pharmaceuticals

esilverman In response to concern over the presence of prescription drugs in water supplies, the European Parliament has added three pharmaceutical compounds to a watch list ...

Europeans throw cold water on Pfizer’s hot streak with Xeljanz rejection

Ryan McBride European authorities have battered expectations for Pfizer's rheumatoid arthritis pill Xeljanz, spurning the drug giant's request for approval over concerns about ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS